Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H32O2 |
Molecular Weight | 304.4669 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 4 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
InChI
InChIKey=YZXBAPSDXZZRGB-DOFZRALJSA-N
InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-
Molecular Formula | C20H32O2 |
Molecular Weight | 304.4669 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 4 |
Optical Activity | NONE |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL239 |
1.2 µM [IC50] | ||
Target ID: CHEMBL235 |
1.6 µM [IC50] | ||
Target ID: CHEMBL3979 |
3.1 µM [IC50] | ||
Target ID: CHEMBL1697668 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23571415 |
602.56 nM [IC50] | ||
Target ID: CHEMBL1743121 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23571415 |
1071.0 nM [IC50] | ||
Target ID: CHEMBL2083 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12036355 |
180.0 nM [Kd] | ||
Target ID: CHEMBL230 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12444669 |
PubMed
Title | Date | PubMed |
---|---|---|
Butylated hydroxyanisole specifically inhibits tumor necrosis factor-induced cytotoxicity and growth enhancement. | 1992 Jul |
|
Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin. | 2001 Dec 15 |
|
Arachidonic acid-induced inhibition of Ca2+ channel currents in retinal glial (Müller) cells. | 2001 Nov |
|
The role of endogenous human Trp4 in regulating carbachol-induced calcium oscillations in HEK-293 cells. | 2002 Apr 19 |
|
A comparative study of the antipyretic effects of indomethacin and dipyrone in rats. | 2002 Jan |
|
LTRPC2 Ca2+-permeable channel activated by changes in redox status confers susceptibility to cell death. | 2002 Jan |
|
Antioxidant and pro-oxidant effects of a manganese porphyrin complex against CYP2E1-dependent toxicity. | 2002 Jul 1 |
|
Cytosolic phospholipase A2 (cPLA2) regulation of human monocyte NADPH oxidase activity. cPLA2 affects translocation but not phosphorylation of p67(phox) and p47(phox). | 2002 Jul 12 |
|
Induction of MnSOD gene by arachidonic acid is mediated by reactive oxygen species and p38 MAPK signaling pathway in human HepG2 hepatoma cells. | 2002 Jun 1 |
|
Leukotriene B4 production in human mononuclear phagocytes is modulated by interleukin-4-induced 15-lipoxygenase. | 2002 Mar |
|
Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole. | 2002 Nov |
|
On the interaction of specific prostaglandin H synthase-2 inhibitors with prostaglandin H synthase-1. | 2002 Oct 25 |
|
Celecoxib reduces skin damage after radiation: selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor. | 2003 Aug |
|
PPARbeta regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation. | 2003 Feb |
|
Inhibition of prostaglandin H2 synthases by salicylate is dependent on the oxidative state of the enzymes. | 2003 Feb |
|
Aldehyde dehydrogenase 3 expression is decreased by clofibrate via PPAR gamma induction in JM2 rat hepatoma cell line. | 2003 Feb 1 |
|
Metallothionein 2A induction by zinc protects HEPG2 cells against CYP2E1-dependent toxicity. | 2003 Feb 15 |
|
Genetic variation in cyclooxygenase 1: effects on response to aspirin. | 2003 Jan |
|
PGE(2) is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells. | 2003 Jul 11 |
|
Eugenol suppresses cyclooxygenase-2 expression in lipopolysaccharide-stimulated mouse macrophage RAW264.7 cells. | 2003 Jun 6 |
|
Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells. | 2003 Mar 15 |
|
Regulation of selenoprotein GPx4 expression and activity in human endothelial cells by fatty acids, cytokines and antioxidants. | 2003 Nov |
|
Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology. | 2003 Oct |
|
Relationship of arachidonic acid concentration to cyclooxygenase-dependent human platelet aggregation. | 2003 Sep |
|
Effects of d-003, a new substance purified from sugar cane wax, on platelet aggregation and plasma levels of arachidonic acid metabolites in healthy volunteers. | 2004 |
|
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells. | 2004 Apr |
|
Polyunsaturated fatty acids are FXR ligands and differentially regulate expression of FXR targets. | 2004 Aug |
|
In vivo and in vitro anti-inflammatory activity of Mangifera indica L. extract (VIMANG). | 2004 Aug |
|
Heme oxygenase-1 protects HepG2 cells against cytochrome P450 2E1-dependent toxicity. | 2004 Feb 1 |
|
Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis. | 2004 Jan |
|
Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. | 2004 Mar 25 |
|
Regulation and inhibition of arachidonic acid omega-hydroxylases and 20-HETE formation. | 2005 |
|
Polyunsaturated fatty acids block dendritic cell activation and function independently of NF-kappaB activation. | 2005 Apr 8 |
|
Cloning, expression, and functional characterization of human cyclooxygenase-1 splicing variants: evidence for intron 1 retention. | 2005 Dec |
|
Fenamates and diltiazem modulate lipid-sensitive mechano-gated 2P domain K(+) channels. | 2005 Dec |
|
A Thrombelastograph whole blood assay for clinical monitoring of NSAID-insensitive transcellular platelet activation by arachidonic acid. | 2005 Jul |
|
Angiotensin II-induced Akt activation through the epidermal growth factor receptor in vascular smooth muscle cells is mediated by phospholipid metabolites derived by activation of phospholipase D. | 2005 Mar |
|
Specificity of receptor-ligand interactions and their effect on dimerisation as observed by electrospray mass spectrometry: bile acids form stable adducts to the RXRalpha. | 2005 Nov |
|
Late-gestation rat myometrial cells express multiple isoforms of phospholipase A2 that mediate PCB 50-induced release of arachidonic acid with coincident prostaglandin production. | 2005 Nov |
|
Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a phospholipase D2 pathway. | 2005 Oct 28 |
|
How dietary arachidonic- and docosahexaenoic- acid rich oils differentially affect the murine hepatic transcriptome. | 2006 Apr 20 |
|
Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. | 2006 Aug |
|
Induction of CYP1A and cyp2-mediated arachidonic acid epoxygenation and suppression of 20-hydroxyeicosatetraenoic acid by imidazole derivatives including the aromatase inhibitor vorozole. | 2006 Aug |
|
Protective effects of a standard extract of Mangifera indica L. (VIMANG) against mouse ear edemas and its inhibition of eicosanoid production in J774 murine macrophages. | 2006 Jun |
|
Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance. | 2006 Jun 27 |
|
Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin? | 2006 May |
|
Metabolites of arachidonic acid in activating platelets and their estimation by radionuclide techniques. | 2006 May-Aug |
|
The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes. | 2006 Nov 25 |
|
Arachidonic acid-induced gene expression in colon cancer cells. | 2006 Oct |
|
Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element. | 2007 Mar |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:17:51 GMT 2023
by
admin
on
Fri Dec 15 15:17:51 GMT 2023
|
Record UNII |
27YG812J1I
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
1467 (Number of products:46)
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
||
|
NCI_THESAURUS |
C2563
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
||
|
LOINC |
90915-0
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
||
|
NCI_THESAURUS |
C68357
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
||
|
LOINC |
88994-9
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
||
|
LOINC |
1889-5
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
||
|
LOINC |
90909-3
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
||
|
LOINC |
88996-4
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
||
|
LOINC |
90916-8
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
||
|
LOINC |
35168-4
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
||
|
LOINC |
35411-8
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
||
|
LOINC |
75110-7
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
15843
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
PRIMARY | |||
|
27YG812J1I
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
PRIMARY | |||
|
36306
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
PRIMARY | |||
|
208-033-4
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
PRIMARY | |||
|
1368625
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
ALTERNATIVE | |||
|
D016718
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
PRIMARY | |||
|
C282
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
PRIMARY | |||
|
100000088503
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
PRIMARY | |||
|
DTXSID4040420
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
PRIMARY | |||
|
444899
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
PRIMARY | |||
|
DB04557
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
PRIMARY | |||
|
ARACHIDONIC ACID
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
PRIMARY | |||
|
1368624
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
PRIMARY | RxNorm | ||
|
m2024
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
PRIMARY | Merck Index | ||
|
506-32-1
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
PRIMARY | |||
|
27YG812J1I
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
PRIMARY | |||
|
SUB21901
Created by
admin on Fri Dec 15 15:17:51 GMT 2023 , Edited by admin on Fri Dec 15 15:17:51 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
LIPID -> FATTY ACID |
Durkee Industrial Foods, Cleveland, Ohio(average value).
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
MAJOR
|
||
|
METABOLITE ACTIVE -> PARENT |
|